Cargando…
The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials
BACKGROUND: Obesity prevalence has increased during the past few decades, causing a pandemic with an influx in other co-morbidities. Many factors influence weight gain in an obesogenic environment therefore strategies for treating obesity may vary from conventional dietary and physical activity inte...
Autores principales: | Jayawardena, Ranil, Francis, Tormalli V., Abhayaratna, Sachith, Ranasinghe, Priyanga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579607/ https://www.ncbi.nlm.nih.gov/pubmed/34758791 http://dx.doi.org/10.1186/s12906-021-03450-8 |
Ejemplares similares
-
Caralluma Fimbriata Supplementation Improves the Appetite Behavior of Children and Adolescents with Prader-Willi Syndrome
por: Griggs, Joanne L., et al.
Publicado: (2015) -
The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults
por: Rao, Amanda, et al.
Publicado: (2021) -
Antiobesogenic and Antiatherosclerotic Properties of Caralluma fimbriata Extract
por: Kamalakkannan, Soundararajan, et al.
Publicado: (2010) -
Antihyperglycemic Activity of Caralluma fimbriata: An In vitro Approach
por: Ashwini, Shenai, et al.
Publicado: (2017) -
Single-Case Study of Appetite Control in Prader-Willi Syndrome, Over 12-Years by the Indian Extract Caralluma fimbriata
por: Griggs, Joanne
Publicado: (2019)